Eylea HD (aflibercept 8 mg) — Regeneron A high-dose VEGF inhibitor jointly developed by Regeneron and Bayer, used to treat wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. FDA approved in August 2023.